Magnesium in PDB 4cyp: Leishmania Major N-Myristoyltransferase in Complex with A Pyrrolidine Inhibitor.

Enzymatic activity of Leishmania Major N-Myristoyltransferase in Complex with A Pyrrolidine Inhibitor.

All present enzymatic activity of Leishmania Major N-Myristoyltransferase in Complex with A Pyrrolidine Inhibitor.:
2.3.1.97;

Protein crystallography data

The structure of Leishmania Major N-Myristoyltransferase in Complex with A Pyrrolidine Inhibitor., PDB code: 4cyp was solved by J.A.Hutton, V.Goncalves, J.A.Brannigan, D.Paape, T.Waugh, S.M.Roberts, A.S.Bell, A.J.Wilkinson, D.F.Smith, R.J.Leatherbarrow, E.W.Tate, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

*Resolution Low / High (Å)*	49.47 / 1.55
*Space group*	P 1 2₁ 1
*Cell size a, b, c (Å), α, β, γ (°)*	48.262, 92.494, 53.717, 90.00, 112.93, 90.00
*R / R_free (%)*	20.499 / 25.24

Other elements in 4cyp:

The structure of Leishmania Major N-Myristoyltransferase in Complex with A Pyrrolidine Inhibitor. also contains other interesting chemical elements:

Chlorine

(Cl)

2 atoms

Magnesium Binding Sites:

The binding sites of Magnesium atom in the Leishmania Major N-Myristoyltransferase in Complex with A Pyrrolidine Inhibitor. (pdb code 4cyp). This binding sites where shown within 5.0 Angstroms radius around Magnesium atom.
In total only one binding site of Magnesium was determined in the Leishmania Major N-Myristoyltransferase in Complex with A Pyrrolidine Inhibitor., PDB code: 4cyp:

Magnesium binding site 1 out of 1 in 4cyp

Go back to

Magnesium Binding Sites List in 4cyp

Magnesium binding site 1 out of 1 in the Leishmania Major N-Myristoyltransferase in Complex with A Pyrrolidine Inhibitor.

Mono view

Stereo pair view

A full contact list of Magnesium with other atoms in the Mg binding site number 1 of Leishmania Major N-Myristoyltransferase in Complex with A Pyrrolidine Inhibitor. within 5.0Å range:

probe	atom	residue	distance (Å)	B	Occ
A:Mg999 b:28.3 occ:1.00	O2A	A:MYA1001	2.8	20.6	1.0
	O	A:LEU175	2.8	22.8	1.0
	N	A:LYS178	2.8	21.8	1.0
	O4A	A:MYA1001	3.0	17.8	1.0
	N	A:LEU180	3.1	23.2	1.0
	N	A:ARG179	3.2	24.2	1.0
	CB	A:LEU180	3.4	22.6	1.0
	N	A:GLU177	3.4	24.6	1.0
	CA	A:LYS178	3.5	23.5	1.0
	C	A:LYS178	3.5	22.8	1.0
	P1A	A:MYA1001	3.6	20.9	1.0
	CB	A:LYS178	3.7	23.6	1.0
	O1A	A:MYA1001	3.7	20.4	1.0
	CA	A:LEU180	3.8	20.9	1.0
	C	A:ARG176	3.8	24.8	1.0
	C	A:GLU177	3.9	26.3	1.0
	C	A:LEU175	3.9	22.4	1.0
	CA	A:GLU177	4.0	26.1	0.5
	CA	A:GLU177	4.0	25.2	0.5
	CA	A:ARG176	4.1	21.9	1.0
	C	A:ARG179	4.1	22.9	1.0
	CG1	A:VAL171	4.1	17.2	1.0
	P2A	A:MYA1001	4.1	19.0	1.0
	CA	A:ARG179	4.2	22.6	1.0
	O	A:LYS178	4.3	28.1	1.0
	O3A	A:MYA1001	4.3	19.1	1.0
	N	A:ALA181	4.3	20.1	1.0
	N	A:ARG176	4.5	23.2	1.0
	CG	A:LYS178	4.6	28.3	1.0
	C	A:LEU180	4.6	22.2	1.0
	O	A:ARG176	4.6	27.9	1.0
	O6A	A:MYA1001	4.7	18.4	1.0
	CG	A:LEU180	4.8	23.4	1.0
	CG2	A:VAL171	4.8	19.3	1.0
	CB	A:VAL171	4.9	16.4	1.0
	O	A:GLU177	5.0	28.4	1.0

Reference:

A.Hutton, V.Goncalves, J.A.Brannigan, D.Paape, M.H.Wright, T.M.Waugh, S.M.Roberts, A.S.Bell, A.J.Wilkinson, D.F.Smith, R.J.Leatherbarrow, E.W.Tate. Structure-Based Design of Potent and Selective Leishmania N- Myristoyltransferase Inhibitors. J.Med.Chem. V. 57 8664 2014.
ISSN: ISSN 0022-2623
PubMed: 25238611
DOI: 10.1021/JM5011397

Page generated: Mon Aug 11 07:21:07 2025

Last articles

Mg in 4FI4
Mg in 4FIG
Mg in 4FI1
Mg in 4FI3
Mg in 4FHX
Mg in 4FHY
Mg in 4FHV
Mg in 4FHW
Mg in 4FFR
Mg in 4FH5

	© Copyright 2008-2020 by atomistry.com
Home \| Site Map \| Copyright \| Contact us \| Privacy